The respiratory virus COVID-19 originated in Wuhan, China, and has spread to more than 100 countries around the world, including the U.S. Rates are rapidly increasing in other European countries, and more recently in the U.S.

Results from the CheckMate 214 clinical trial show that combined therapy with two immunotherapy drugs, nivolumab and ipilimumab, can be very effective in the treatment of renal cell carcinoma, the most common type of kidney cancer.

Research conducted at Roswell Park Comprehensive Cancer Center provides additional evidence of the advantages of getting the Gardasil® vaccine to protect against HPV (the human papillomavirus).

Roswell Park patients who enrolled in clinical trials provided critical information that led to FDA approval of Herceptin (breast cancer), Gleevec (leukemia), Yervoy (melanoma) and other drugs — and consequently, they were among the first patients to benefit from those drugs.

Due to the stigma of a cancer diagnosis at the time, two tried successfully to keep their diagnoses secret — at least during their terms in office.